BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,426 | -20.2% | 2,608 | -3.7% | 0.01% | -15.4% |
| Q2 2023 | $123,376 | +3.5% | 2,708 | -7.9% | 0.01% | -7.1% |
| Q1 2023 | $119,218 | -30.0% | 2,939 | -12.0% | 0.01% | -30.0% |
| Q4 2022 | $170,250 | +8.4% | 3,340 | +14.3% | 0.02% | 0.0% |
| Q3 2022 | $157,000 | -15.6% | 2,921 | +0.7% | 0.02% | -13.0% |
| Q2 2022 | $186,000 | -11.8% | 2,901 | +6.8% | 0.02% | 0.0% |
| Q1 2022 | $211,000 | -9.4% | 2,716 | 0.0% | 0.02% | -11.5% |
| Q4 2021 | $233,000 | +6.9% | 2,716 | 0.0% | 0.03% | 0.0% |
| Q3 2021 | $218,000 | -51.3% | 2,716 | -50.0% | 0.03% | -7.1% |
| Q2 2021 | $448,000 | +95.6% | 5,432 | +100.0% | 0.03% | -6.7% |
| Q1 2021 | $229,000 | +5.0% | 2,716 | 0.0% | 0.03% | -9.1% |
| Q4 2020 | $218,000 | -0.5% | 2,716 | -0.4% | 0.03% | -15.4% |
| Q3 2020 | $219,000 | -6.4% | 2,728 | +0.4% | 0.04% | -9.3% |
| Q2 2020 | $234,000 | +4.0% | 2,716 | -1.8% | 0.04% | -10.4% |
| Q1 2020 | $225,000 | -2.6% | 2,766 | 0.0% | 0.05% | +26.3% |
| Q4 2019 | $231,000 | -4.5% | 2,766 | 0.0% | 0.04% | -9.5% |
| Q3 2019 | $242,000 | +2.5% | 2,766 | -4.2% | 0.04% | 0.0% |
| Q2 2019 | $236,000 | +4.9% | 2,886 | +4.3% | 0.04% | 0.0% |
| Q1 2019 | $225,000 | +9.8% | 2,766 | -11.2% | 0.04% | -12.5% |
| Q4 2018 | $205,000 | -14.6% | 3,115 | 0.0% | 0.05% | 0.0% |
| Q3 2018 | $240,000 | +3.4% | 3,115 | -1.1% | 0.05% | -5.9% |
| Q2 2018 | $232,000 | +13.2% | 3,150 | 0.0% | 0.05% | +8.5% |
| Q1 2018 | $205,000 | -2.4% | 3,150 | -3.1% | 0.05% | -2.1% |
| Q4 2017 | $210,000 | +2.9% | 3,250 | 0.0% | 0.05% | -4.0% |
| Q3 2017 | $204,000 | -6.4% | 3,250 | -22.6% | 0.05% | -15.3% |
| Q1 2017 | $218,000 | -2.2% | 4,200 | -10.2% | 0.06% | -15.7% |
| Q3 2016 | $223,000 | +3.7% | 4,678 | -1.7% | 0.07% | -4.1% |
| Q2 2016 | $215,000 | -47.8% | 4,760 | -19.1% | 0.07% | -53.8% |
| Q2 2015 | $412,000 | +5.6% | 5,883 | +3.2% | 0.16% | +5.3% |
| Q1 2015 | $390,000 | +18.5% | 5,702 | +27.2% | 0.15% | +11.1% |
| Q4 2014 | $329,000 | +2.2% | 4,482 | 0.0% | 0.14% | -4.9% |
| Q3 2014 | $322,000 | -0.6% | 4,482 | 0.0% | 0.14% | -2.7% |
| Q2 2014 | $324,000 | -1.8% | 4,482 | 0.0% | 0.15% | -9.3% |
| Q1 2014 | $330,000 | +7.8% | 4,482 | +1.9% | 0.16% | +1.9% |
| Q4 2013 | $306,000 | – | 4,400 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |